ASTRAZEN logo

Astrazeneca Pharma IND LT

ASTRAZEN·NSE·
6,917.50 -34.00 (-0.49%)
Market Cap17336.30 Cr
PE Ratio92.22
Volume3,422
Day High - Low7014.50 - 6885.50
52W High-Low9849.50 - 6885.50
DocStoX Score
4.8/10
Weak
Fair Value
Sign in to see
ROE
21.53%
Strong
P/E
92.22x
Expensive
Debt / Equity
0.13
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day6886
7015
52W6886
9850
DocStoX take

Supported by risk (8.6) and growth (7.8), but held back by momentum (0.0). Risk looks strong at 8.6, but that is offset by valuation at 0.0 and momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.8
/10
Weak
Quality
Solid
ROE 21.5%
Valuation
Expensive
P/E 92.2×
Growth
Strong
Revenue +22.8% 5Y CAGR
Risk
Low risk
D/E 0.13
Momentum
Weak
1% of 52-week range

At a glance

Market Cap
₹17,336 Cr
52W High / Low
₹9850 / ₹6886
Dividend Yield
0.50%
Promoter Holding
75.00%
EPS (TTM)
₹75.01
Book Value
₹348.32

Key highlights

  • Low leverage — D/E 0.13
  • Capital works hard — ROCE 29%
  • Profitable in all of the last 5 years
  • Valuation is weak (0.0/10)
  • Momentum is weak (0.0/10)
4 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

ASTRAZENECA PHARMA IND LT peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.